Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Biotechnology 79 15.7%
Current Price (07/17) $230.86
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 13,713.1
Sales Growth Forecast 6.8%
Net Profit Margin 37.8%
Projected Shares Outstanding 180.08
EPS - Five year Forecast $39.92
Average P/E Ratio 12.0
Projected Average Price $479.06
Price Appreciation (Annualized) 15.7%
Annual Dividend Yield 0.0%
Projected Annual Return 15.7%
Quality
Financial Strength 84 21.0
EPS Stability 76 19.1
Industry Sales Growth Rate 16.5% 5.1
Industry Net Profit Margin 29.0% 16.3
Calculated Quality Rating 61.5
Fool CAPS

Total Players

1001 Outperforms
70 Underperforms
 

All-Stars (249)

238 Outperforms (96%)
11 Underperforms
 
Fundamental Data Updated: 07/05/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 15.1%
BIIB 79 15.7%
BSTC 80 15.3%
REGN 80 22.7%
RGEN 71 15.8%

Top In Healthcare

Ticker Quality PAR
ALGN 99 21.4%
ABMD 82 19.1%
JAZZ 94 15.1%
CMD 92 14.1%
ABBV 87 15.4%